EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aly as a Key Regulator of DNA Repair and Immune Evasion in Esophageal Squamous Cell Carcinoma Radioresistance

Shizhen Ding, Huichao Liang, Jianlin Wang, Hong Zhu, Xiaofang Li, Qiu Zong, Xueqing Ma, Xujing Lu, Zhiqiang Sun, Wei Li, Judong Luo

International Journal of Radiation Oncology*Biology*Physics · 2026

DOI: 10.1016/j.ijrobp.2026.04.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026. Verfasst von Shizhen Ding und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medica…. Hauptthemen laut MEDLINE: Radiation Tolerance, DNA Repair, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tongji University, National Natural Science Foundation of China, Changzhou Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Esophageal squamous cell carcinoma (ESCC) is frequently refractory to radiation therapy, in part because of inefficient DNA damage repair and an immunosuppressive tumor microenvironment. We investigated whether ALYREF (Aly) coordinates radioresistance and immune evasion in ESCC. METHODS AND MATERIALS: Aly expression and its clinical associations were analyzed in the Cancer Genome Atlas (TCGA) cohorts and validated by immunohistochemistry in an independent ESCC cohort. Aly was genetically silenced or overexpressed in ESCC cell lines, followed by irradiation and subsequent assessment of clonogenic survival, reactive oxygen species (ROS) production, and apoptosis. Multi-omics analyses and mechanistic studies (protein interaction modeling, immunofluorescence, and DNA damage readouts) were performed to define pathways linking Aly to radioresponse and immune contexture. RESULTS: Aly was overexpressed in ESCC and associated with adverse clinical outcomes. Aly depletion suppressed ESCC growth and enhanced radiosensitivity, characterized by increased radiation-induced reactive oxygen species and apoptosis, as well as reduced clonogenic survival. Aly's loss was accompanied by changes consistent with impaired resolution of DNA double-strand break repair and activation of inflammatory signaling. Mechanistically, Aly engaged REV7-associated nuclear programs and Hsp70-linked cytoprotective signaling, thereby supporting DNA damage tolerance and survival after irradiation, and was correlated with an immunosuppressive contexture. CONCLUSIONS: Aly functions as a dual regulator of ESCC radioresistance by integrating DNA repair capacity and immune suppression. Targeting Aly may represent a strategy to radiosensitize ESCC and potentially improve responses to combined radiation therapy-immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiation ToleranceDNA RepairEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaTranscription FactorsNuclear ProteinsImmune EvasionDNA-Binding ProteinsHumansReactive Oxygen SpeciesApoptosisCell Line, TumorTumor Microenvironment

Substanzen

Reactive Oxygen SpeciesTranscription FactorsNuclear ProteinsDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, China; Department of Geriatrics, The Affiliat…
  • Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, China.
  • Department of Radiotherapy, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Radiotherapy, Changzhou Fourth People's Hospital, Changzhou, China.
  • Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, China. Electronic address: jungler@sina.cn.
  • Clinical Nutrition Department, The Tenth People's Hospital Affiliated to Tongji University, Shanghai, China. Electronic address: winni0423@126.com.

Förderung

  • Tongji University
  • National Natural Science Foundation of China
  • Changzhou Science and Technology Bureau
  • Tongji Hospital
  • Nanjing Medical University

Zitieren

APA

Ding, S., Liang, H., Wang, J., Zhu, H., Li, X., Zong, Q., Ma, X., Lu, X., Sun, Z., Li, W., & Luo, J. (2026). Aly as a Key Regulator of DNA Repair and Immune Evasion in Esophageal Squamous Cell Carcinoma Radioresistance. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2026.04.023

Vancouver

Ding S, Liang H, Wang J, Zhu H, Li X, Zong Q, et al. Aly as a Key Regulator of DNA Repair and Immune Evasion in Esophageal Squamous Cell Carcinoma Radioresistance. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2026.04.023

BibTeX
@article{Ding2026,
  author = {Ding, Shizhen and Liang, Huichao and Wang, Jianlin and Zhu, Hong and Li, Xiaofang and Zong, Qiu and Ma, Xueqing and Lu, Xujing and Sun, Zhiqiang and Li, Wei and Luo, Judong},
  title = {Aly as a Key Regulator of DNA Repair and Immune Evasion in Esophageal Squamous Cell Carcinoma Radioresistance},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  doi = {10.1016/j.ijrobp.2026.04.023}
}
Kostenlos starten →